RxDoctor Payments Data

William Woodall, MD

Neurological Surgery · Birmingham, ALNPI 1578513925

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Boston Scientific at 30.5% of the total.

$3,378in general payments, 2019–2025

Across 140 payments — averaging $24.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Medtronic$509
  • Providence Medical Technology, Inc.$403
  • Baxter Healthcare$381
  • Globus Medical$201
  • Abbott$165
  • plus $690 from 16 others

What the payments were for

  • Travel & lodging$170%
  • Food & beverage$3,361100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,378 in reported general payments places this provider in the 55th percentile of 97 neurological surgery providers in Alabama.

See all neurological surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$144,832
Medicare patients
159
Services billed
460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen246$2,163
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen149$1,146
Methocarbamol164$986
Methylprednisolone102$864
Gabapentin74$739
Celecoxib15$465
Cyclobenzaprine Hcl38$304
Tizanidine Hcl55$280
Meloxicam52$192
Pregabalin19$179
Ondansetron Hcl18$169
Tramadol Hcl46$132
Diazepam18$14

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →